相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor A Randomized Trial
Heikki Joensuu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Successful treatment of nilotinib-induced pleural effusion with prednisone
K Chakraborty et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2012)
Pleural effusions due to dasatinib
Anupama G. Brixey et al.
CURRENT OPINION IN PULMONARY MEDICINE (2010)
Congestive heart failure during imatinib mesylate treatment
Gina Turrisi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib
David Marin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Dasatinib-Induced Pleural Effusions: A Lymphatic Network Disorder?
Mark Goldblatt et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure
Alfonso Quintas-Cardama et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I trial of intermittent administration of sorafenib (BAY 43-9006) for patients (pts) with refractory/relapsed acute myelogenous leukemia (AML)
A. Quintas-Cardama et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: A randomized phase 2 trial
Hagop Kantarjian et al.
BLOOD (2007)
Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005
Jaap Verweij et al.
EUROPEAN JOURNAL OF CANCER (2007)
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkela et al.
NATURE MEDICINE (2006)
Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib
AL Dewar et al.
BLOOD (2005)
Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group
I Judson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume
GC Jayson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib
M Breccia et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
KIT-negative gastrointestinal stromal tumors - Proof of concept and therapeutic implications
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
MC Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target:: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study
J Verweij et al.
EUROPEAN JOURNAL OF CANCER (2003)
Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia
JC Barton et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review
M Miettinen et al.
EUROPEAN JOURNAL OF CANCER (2002)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase I study
AT van Oosterom et al.
LANCET (2001)
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
DA Tuveson et al.
ONCOGENE (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The histopathological differential diagnosis of gastrointestinal stromal tumours
JFG van Roggen et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
分享论文
